|
|
Volumn 31, Issue 5, 2013, Pages 374-
|
|
FDA moves on breakthrough therapies.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,3 BENZODIOXOLE DERIVATIVE;
AMINOPHENOL DERIVATIVE;
AMINOPYRIDINE DERIVATIVE;
IVACAFTOR;
LUMACAFTOR;
N-(2,4-DI-TERT-BUTYL-5-HYDROXYPHENYL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE;
QUINOLONE DERIVATIVE;
DRUG APPROVAL;
NEOPLASM;
NOTE;
ORGANIZATION AND MANAGEMENT;
TERMINAL CARE;
UNITED STATES;
AMINOPHENOLS;
AMINOPYRIDINES;
BENZODIOXOLES;
DRUG APPROVAL;
NEOPLASMS;
QUINOLONES;
TERMINAL CARE;
UNITED STATES;
|
|
EID: 84884154318
PISSN: None
EISSN: 15461696
Source Type: None
DOI: 10.1038/nbt0513-374a Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
